Eversept Partners, LP

Position in NVO — Novo Nordisk A S

CIK 1697013 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,112,742

-$3,967,874 QoQ

Shares Held

169,227

-22.3% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#166

of 1,348 holders

Holding Since

Mar 2024

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $59,814,180 across 4 Drug Manufacturers - General names. NVO ranks #3 (13.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc	481,833	$25,257,685
2	LLY	ELI LILLY & Co	20,116	$24,127,735
3	NVO	Novo Nordisk A S This page	169,227	$8,112,742
4	AMRN	Amarin Corp Plc\Uk	145,296	$2,316,018

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,112,742	169,227	-22.3%	Shares	Sole	2026-08-14
2025-09-30	$12,080,616	217,708	+48.1%	Shares	Sole	2025-11-14
2024-06-30	$20,976,499	146,956	+135.7%	Shares	Sole	2024-08-14
2024-03-31	$8,004,969	62,344	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.